UnknownPhase 2

Effect on Tear Functions of Pretarsal and Preseptal Techniques of Botulinum Toxin Type A Injection in Hemifacial Spasm

Thailand26 participantsStarted 2012-04

Plain-language summary

The purpose of this study is to determine whether pretarsal and preseptal techniques of Botulinum toxin type A injection have any effect on tear functions.

Who can participate

Age range20 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patient diagnosed with hemifacial spasm Exclusion Criteria: * previous history of botulinum toxin treatment for hemifacial spasm * ocular surface disorders * tear disorders * evidence of infection at or around eyelids * pregnant woman * other neurologic disease, i.e. OMG * coagulopathy or treatment with thrombolytic agent * treatment with aminoglycosides, chloroquine, hydroxychloroquine

What they're measuring

tear break up time

Timeframe: change from baseline in tear break up time at 12 weeks

Trial details

NCT IDNCT01564979

SponsorKhon Kaen University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2012-09

Contact for this trial

kitthisak kitthaweesin, ND

6643348383 kitthisak@hotmail.com

View on ClinicalTrials.gov More Hemifacial Spasm trials